A recent report from Renub Research, titled "Global Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028," offers a thorough analysis of the industry and market share knowledge. The report also includes research on regions, competitors, and the recent expansion of the Global Vaccine Market.
The Global Vaccine Market is expected to grow to USD 92.32 billion by 2028, According to Renub Research. The global health has dramatically benefited from vaccination. Smallpox and rinderpest have both been eliminated. Since the establishment of the WHO's Expanded Programme of Immunization and the Global Alliance for Vaccine and Immunization, vaccination coverage against many serious infectious diseases of children has increased dramatically globally. The eradication of polio is almost complete, and the success in controlling measles makes it a potential candidate for eradication.
Despite these accomplishments, 6.6 million kids still pass away from preventable diseases like pneumonia and diarrhea each year, accounting for about half of all pediatric fatalities, according to the NCBI. Therefore, increased use of the rotavirus and pneumococcal conjugate vaccines should result in more children living longer. Some non-infectious diseases may eventually be prevented or treated differently, thanks to vaccines. Progress has already been made with therapeutic cancer vaccines; upcoming potential targets include addiction, diabetes, hypertension, and Alzheimer's disease.
Governments worldwide are now aware of how crucial vaccination programs are to lowering the prevalence of infectious diseases. As a result, numerous nations have implemented extensive immunization campaigns to reach at-risk populations and stop outbreaks. These governmental initiatives are boosting the demand for vaccines. This aligns with the continued severe concern over the high child mortality rate caused by infectious diseases, especially in developing nations. To combat this problem, vaccination campaigns are being stepped up in these areas, driving up demand for vaccines. As a result of the participation of numerous international organizations and foundations, the vaccine market in endemic regions is growing. The Global Vaccine Market is anticipated to expand at a CAGR of 8.64% between 2022 and 2028.
The last ten years have seen significant advancements in vaccine technology, significantly altering the course of vaccine development. Genetic engineering has sparked numerous improvements in vaccine development programs that have produced new goods. These techniques have been used to create several virus vaccines that utilize the virus's attenuated form. New technologies also make it possible to detect viruses more quickly and maintain concentration levels that are high enough to trigger an immune response.
The pneumococcal vaccine is anticipated to maintain a sizable share of the Global Vaccine Market.
The pneumococcal vaccine commands a sizable portion of the Global Vaccine Market because it effectively prevents serious illnesses caused by the Streptococcus pneumoniae bacteria. Pneumonia, meningitis, otitis media, and invasive pneumococcal disease (IPD) are a few of these, and they can all be fatal, especially in vulnerable populations like young children and the older. The vaccine also helps prevent less severe conditions like sinusitis and bronchitis.
Vaccine Market Share – The Global Vaccine Market has been covered from 14 viewpoints:
- Influenza
- HPV
- Zoster
- MMR
- Pneumococcal
- Meningococcal
- Hepatitis
- DTap/Tdap
- Travel Miscellaneous
- HIB
- Combos
- Polio
- Rotavirus
- Varicella
In coming years, it is anticipated that influenza vaccines will continue to hold a significant position in the Global Vaccine Market.
The high incidence of influenza among the older and those with underlying medical conditions generates significant demand. Patients and parents are drawn to the vaccine because of how well it prevents severe complications and how safe it is. The rise in demand has also been aided by increased government support and public awareness of influenza and its prevention. Their acceptance has grown due to the creation of fresh, improved vaccines like the quadrivalent influenza shot. The seasonal variation of the influenza virus, the disease's global spread, and manufacturer competition all help to sustain market growth.
Vaccinated People – Global Vaccine Market has been covered from 13 viewpoints:
- Influenza
- Cervical Cancer
- Zoster
- MMR
- Pneumococcal
- Meningococcal
- Hepatitis
- DTap/Tdap
- HIB
- Combos
- Polio
- Rotavirus
- Varicella
The Global Vaccine Market is anticipated to remain dominated by the United States.
The United States maintains its leadership in the global vaccination industry thanks to a solid RD foundation that includes top universities and pharmaceutical companies and keeps it in front of vaccine development. A sizable, tightly controlled vaccine market also draws investment and keeps up demand. Government assistance strengthens the vaccine industry further by providing funding and advocating for vaccination. Thanks to its extensive reach and successful vaccine development and production history, the US is still a significant player in the global market. The country continues to lead due in part to its high vaccination rates, rising vaccination rates awareness and improvements in vaccine technology.
Country – Global Vaccine Market has been covered from 21 viewpoints:
- United States
- Canada
- Mexico
- United Kingdom
- Germany
- France
- Russia
- Italy
- Spain
- Switzerland
- India
- China
- Japan
- Australia
- South Korea
- Brazil
- Argentina
- Saudi Arabia
- UAE
- South Africa
- Rest of the World
Market and volume growth for pediatric vaccines are anticipated in the upcoming years.
Global demand for pediatric vaccines is rising as people become more aware of the value of immunization, particularly for children. Pediatric vaccines are also necessary to protect children from infectious diseases like measles and mumps, which are becoming more common. The creation of more recent and secure vaccines has also increased demand. Government support, including financial aid, improves children's access to vaccines. Improved cold chain management also guarantees vaccine availability and reduces waste. The pediatric vaccine market is also growing due to rising birth rates, urbanization, and wealth.
Category – Global Vaccine Market has been covered from 2 viewpoints:
- Adult
- Pediatric
Competitive Landscape
AstraZeneca plc, Sanofi Pasteur, Pfizer Inc., CSL Limited, and GlaxoSmithKline plc are some top businesses vying for market share in the Global Vaccine Market.
Company Insights:
- Overview
- Recent Development and Initiatives
- Sales Analysis
Company Analysis:
- GlaxoSmithKline plc,
- AstraZeneca plc,
- Sanofi Pasteur,
- Pfizer Inc.,
- CSL Limited